Leitlinie
Reevaluating guideline concordance in inflammatory breast cancer: addressing unrecognized complexities and evolving therapeutic strategies
Breast Communications · 2025
DOI: 10.21037/bc-25-17 ↗Kurz gefasst
Leitlinie in der Zeitschrift Breast Communications, 2025. Verfasst von Janhavi Venkataraman und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Venkataraman, J., Oner, M., & Mokbel, K. (2025). Reevaluating guideline concordance in inflammatory breast cancer: addressing unrecognized complexities and evolving therapeutic strategies. Breast Communications. https://doi.org/10.21037/bc-25-17
Vancouver
Venkataraman J, Oner M, Mokbel K. Reevaluating guideline concordance in inflammatory breast cancer: addressing unrecognized complexities and evolving therapeutic strategies. Breast Communications. 2025. doi:10.21037/bc-25-17
BibTeX
@article{Venkataraman2025,
author = {Venkataraman, Janhavi and Oner, Muharrem and Mokbel, Kefah},
title = {Reevaluating guideline concordance in inflammatory breast cancer: addressing unrecognized complexities and evolving therapeutic strategies},
journal = {Breast Communications},
year = {2025},
doi = {10.21037/bc-25-17}
}
EUVIMED